Board of Directors

Roger Vertrees, Ph.D.

Chairman of the Board, Chief Science & Technology Officer

Roger is a Clinical Perfusionist Emeritus, and he received his Ph.D. from the University of Texas in Biomedical Sciences with a concentration in Experimental Oncologic Pathology. Roger has over 30 years of experience in whole-body hyperthermia. Roger has overseen preclinical animal studies in hyperthermia and was instrumental in the design and administration of the only human trials of lung and ovarian cancer patients. 

Jay Winetz.png

Jan Winetz, M.D.

Chief Clinical Officer

Jan is Board Certified in Internal Medicine and Nephrology. Jan graduated from the Cornell University Medical College with a residency, and then he served as a Chief Resident at S.U.N.Y. affiliated hospitals at Buffalo, N.Y. Jan also served a fellowship at Stanford University Medical Center where he won two National Kidney Foundation Fellowships for his research. Jan has multiple peer-reviewed publications and has been a practicing Nephrologist for over 30 years. Jan was instrumental in the company’s Phase 1 ovarian hyperthermia trials.

Jay Smith

Board Member, Secretary

Jay was a certified public accountant with a large national firm and has over 30 years of experience as a financial executive. Jay has successfully established and managed businesses in manufacturing, distribution, importing, and agriculture. Jay initially joined the company as the interim CFO and helped support capital raising efforts. Jay holds a BS and an MBA from the University of Southern California. 

Jay Smith.jpg
Gary Keeling.jpg

Gary Keeling

Board Member

Gary has been active in the hyperthermia sector since 1992 and received the first FDA IDE to treat AIDS patients with whole-body hyperthermia in 1995. Gary’s company received the first FDA clearance for an intraperitoneal hyperthermia device in 1999 and has been commercially operating the HIPEC Procedure. This procedure is used by surgical oncologists to treat advanced abdominal cancer and is a standard of care in over 172 prestigious hospitals, including Mass General, Cleveland Clinic, Johns Hopkins, MD Anderson, and the Mayo Clinic. Gary has invented and patented two abdominal drainage catheters which are used in surgery every day throughout the world. He also developed and patented a chemotherapy sensitizing solution and co-wrote in-vitro and in-vivo study protocols for the solution. Gary attended the University of Pittsburgh in Pittsburgh, Pennsylvania, and received a BS in Economics.